A1: no patient specific details have been provided.Therefore, the patient initials reflect the study number with codes for the hospital and patient.H3 other code: as the device remains implanted, no further investigation can be performed.H6 evaluation codes investigation findings c19 refers to the product history review: a review of the manufacturing records indicated the lot met all pre-release specifications.The physician stated that there is no allegation against the gore-tex stretch vascular graft and that the graft did not contribute to the steal syndrome.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
Gore received an adverse event alert from a retrospective vascular graft study.On (b)(6) 2016, the patient underwent surgical treatment for a humero axillary dialysis access with a gore-tex® stretch vascular graft.The device was implanted and retained and there were no adverse events during the procedure.The patient was discharged home 1 week later.The first order to dialyze through the graft was on (b)(6) 2016 and was successful.On (b)(6) 2016, the patient presented with a vascular steal syndrome on the humero-axillary prosthetic line.Professor rinckenbach stated that there is no allegation against the gore-tex stretch vascular graft and that the graft did not contribute to the steal syndrome.There was a reintervention on (b)(6) 2016, namely banding of the arterio-venous anastomosis.The patient was discharged home on (b)(6) 2016 and an ultrasound performed on (b)(6) 2016 showed that everything was ok.
|